NTRK1 and melanoma: These data demonstrate that UPR activation by the reducing agent DTT promotes TrkAIII mRNA expression and alters TrkA protein expression, resulting in the expression of a phosphorylated TrkA isoform, consistent with TrkAIII, in A375 melanoma cells.